AMRZ Fundamental Analysis - AMRIZE LTD

Fundamental Rating

We assign a fundamental rating of 2 out of 10 to AMRZ. AMRZ was compared to 13 industry peers in the Construction Materials industry. AMRZ has a bad profitability rating. Also its financial health evaluation is rather negative. AMRZ does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year AMRZ was profitable.

1.2 Ratios

With a Return On Assets value of 5.30%, AMRZ perfoms like the industry average, outperforming 46.15% of the companies in the same industry.

Looking at the Return On Equity, with a value of 9.88%, AMRZ is doing worse than 61.54% of the companies in the same industry.

AMRZ has a Return On Invested Capital of 7.43%. This is comparable to the rest of the industry: AMRZ outperforms 53.85% of its industry peers.

		Industry Rank	Sector Rank
ROA	5.3%
ROE	9.88%
ROIC	7.43%

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

AMRZ has a Profit Margin of 10.89%. This is in the better half of the industry: AMRZ outperforms 61.54% of its industry peers.

AMRZ has a better Operating Margin (18.16%) than 69.23% of its industry peers.

AMRZ's Gross Margin of 26.23% is on the low side compared to the rest of the industry. AMRZ is outperformed by 69.23% of its industry peers.

		Industry Rank	Sector Rank
OM	18.16%
PM (TTM)	10.89%
GM	26.23%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

AMRZ has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

The number of shares outstanding for AMRZ remains at a similar level compared to 1 year ago.

AMRZ has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.55 indicates that AMRZ is not a great score, but indicates only limited risk for bankruptcy at the moment.

AMRZ has a Altman-Z score of 2.55. This is comparable to the rest of the industry: AMRZ outperforms 46.15% of its industry peers.

AMRZ has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.

The Debt to Equity ratio of AMRZ (0.45) is comparable to the rest of the industry.

		Industry Rank	Sector Rank
Debt/Equity	0.45
Debt/FCF	N/A
Altman-Z	2.55

ROIC/WACC0.72

WACC10.28%

2.3 Liquidity

A Current Ratio of 1.45 indicates that AMRZ should not have too much problems paying its short term obligations.

Looking at the Current ratio, with a value of 1.45, AMRZ is doing worse than 69.23% of the companies in the same industry.

A Quick Ratio of 0.97 indicates that AMRZ may have some problems paying its short term obligations.

The Quick ratio of AMRZ (0.97) is worse than 69.23% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	1.45
Quick Ratio	0.97

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.26% over the past year.

AMRZ shows a small growth in Revenue. In the last year, the Revenue has grown by 0.23%.

EPS 1Y (TTM)33.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

Revenue 1Y (TTM)0.23%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 11.65% on average over the next years. This is quite good.

The Revenue is expected to grow by 5.08% on average over the next years.

EPS Next Y3.59%

EPS Next 2Y8.96%

EPS Next 3Y11.02%

EPS Next 5Y11.65%

Revenue Next Year3.3%

Revenue Next 2Y3.78%

Revenue Next 3Y4.43%

Revenue Next 5Y5.08%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 24.24, which indicates a rather expensive current valuation of AMRZ.

AMRZ's Price/Earnings ratio is a bit cheaper when compared to the industry. AMRZ is cheaper than 61.54% of the companies in the same industry.

The average S&P500 Price/Earnings ratio is at 26.92. AMRZ is around the same levels.

The Price/Forward Earnings ratio is 20.37, which indicates a rather expensive current valuation of AMRZ.

Compared to the rest of the industry, the Price/Forward Earnings ratio of AMRZ indicates a somewhat cheap valuation: AMRZ is cheaper than 69.23% of the companies listed in the same industry.

AMRZ is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.46, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	24.24
Fwd PE	20.37

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AMRZ indicates a somewhat cheap valuation: AMRZ is cheaper than 69.23% of the companies listed in the same industry.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	11.85

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AMRZ does not grow enough to justify the current Price/Earnings ratio.

PEG (NY)6.75

PEG (5Y)N/A

EPS Next 2Y8.96%

EPS Next 3Y11.02%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

AMRZ does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

AMRIZE LTD

NYSE:AMRZ (12/26/2025, 8:04:00 PM)

After market: 55.75 0 (0%)

55.75

-0.1 (-0.18%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryConstruction Materials

Earnings (Last)10-28 2025-10-28/amc

Earnings (Next)N/A N/A

Inst Owners37.75%

Inst Owner ChangeN/A

Ins Owners7.13%

Ins Owner Change49.27%

Market Cap30.83B

Revenue(TTM)11.70B

Net Income(TTM)1.27B

Analysts77.5

Price TargetN/A

Short Float %1.78%

Short Ratio2.05

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr YearsN/A

Div Non Decr YearsN/A

Ex-DateN/A

Surprises & Revisions

EPS beat(2)1

Avg EPS beat(2)-14.79%

Min EPS beat(2)-33.5%

Max EPS beat(2)3.92%

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)0

Avg Revenue beat(2)-5.16%

Min Revenue beat(2)-8.34%

Max Revenue beat(2)-1.97%

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)0%

EPS NQ rev (3m)N/A

EPS NY rev (1m)-2.1%

EPS NY rev (3m)-7.31%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0.31%

Revenue NY rev (3m)0.17%

Valuation

		Industry Rank	Sector Rank
PE	24.24
Fwd PE	20.37
P/S	2.63
P/FCF	N/A
P/OCF	N/A
P/B	2.39
P/tB	14.37
EV/EBITDA	11.85

EPS(TTM)2.3

EY4.13%

EPS(NY)2.74

Fwd EY4.91%

FCF(TTM)N/A

FCFYN/A

OCF(TTM)N/A

OCFYN/A

SpS21.16

BVpS23.33

TBVpS3.88

PEG (NY)6.75

PEG (5Y)N/A

Graham Number34.74

Profitability

		Industry Rank	Sector Rank
ROA	5.3%
ROE	9.88%
ROCE	10.18%
ROIC	7.43%
ROICexc	7.72%
ROICexgc	16.16%
OM	18.16%
PM (TTM)	10.89%
GM	26.23%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-ScoreN/A

Asset Turnover0.49

Health

		Industry Rank	Sector Rank
Debt/Equity	0.45
Debt/FCF	N/A
Debt/EBITDA	1.93
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	1.45
Quick Ratio	0.97
Altman-Z	2.55

F-ScoreN/A

WACC10.28%

ROIC/WACC0.72

Cap/Depr(3y)69.39%

Cap/Depr(5y)N/A

Cap/Sales(3y)5.14%

Cap/Sales(5y)N/A

Profit Quality(3y)137.06%

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)33.26%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%N/A

EPS Next Y3.59%

EPS Next 2Y8.96%

EPS Next 3Y11.02%

EPS Next 5Y11.65%

Revenue 1Y (TTM)0.23%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%N/A

Revenue Next Year3.3%

Revenue Next 2Y3.78%

Revenue Next 3Y4.43%

Revenue Next 5Y5.08%

EBIT growth 1Y13.63%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year45.34%

EBIT Next 3Y18.7%

EBIT Next 5Y14.65%

FCF growth 1Y16.64%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y12.08%

OCF growth 3YN/A

OCF growth 5YN/A

AMRIZE LTD / AMRZ FAQ

Can you provide the ChartMill fundamental rating for AMRIZE LTD?

ChartMill assigns a fundamental rating of 2 / 10 to AMRZ.

What is the valuation status for AMRZ stock?

ChartMill assigns a valuation rating of 2 / 10 to AMRIZE LTD (AMRZ). This can be considered as Overvalued.

How profitable is AMRIZE LTD (AMRZ) stock?

AMRIZE LTD (AMRZ) has a profitability rating of 2 / 10.

What are the PE and PB ratios of AMRIZE LTD (AMRZ) stock?

The Price/Earnings (PE) ratio for AMRIZE LTD (AMRZ) is 24.24 and the Price/Book (PB) ratio is 2.39.

Can you provide the financial health for AMRZ stock?

The financial health rating of AMRIZE LTD (AMRZ) is 3 / 10.

AMRIZE LTD (AMRZ) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

AMRIZE LTD / AMRZ FAQ

Can you provide the ChartMill fundamental rating for AMRIZE LTD?

What is the valuation status for AMRZ stock?

How profitable is AMRIZE LTD (AMRZ) stock?

What are the PE and PB ratios of AMRIZE LTD (AMRZ) stock?

Can you provide the financial health for AMRZ stock?